We are live on
!
Find out more
EPGL
Evelyn Partners Group Ltd Portfolio holdings
AUM
$46.9B
This Fund
S&P 500
This Quarter
Est. Return
-2.15%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$46.9B
AUM Growth
–
Cap. Flow
+$5.86B
Cap. Flow
% of AUM
12.5%
Top 10 Holdings %
Top 10 Hldgs %
93.6%
Holding
551
New
551
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$421M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$409M |
| 3 |
Amazon
AMZN
|
+$395M |
| 4 |
Microsoft
MSFT
|
+$378M |
| 5 |
NVIDIA
NVDA
|
+$261M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 89.62% |
| 2 | Technology | 2.91% |
| 3 | Financials | 2.09% |
| 4 | Communication Services | 1.32% |
| 5 | Consumer Discretionary | 1.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SOLS
301
Solstice Advanced Materials
SOLS
$9.68B
| $121K | ﹤0.01% |
+1,364
| New | +$113K |
|
302
W.W. Grainger
GWW
$60.2B
| $117K | ﹤0.01% |
+86
| New | +$106K |
|
303
Monolithic Power Systems
MPWR
$68.9B
| $116K | ﹤0.01% |
+84
| New | +$126K |
|
304
AerCap
AER
$23.8B
| $116K | ﹤0.01% |
+795
| New | +$113K |
|
305
Mercado Libre
MELI
$92.3B
| $115K | ﹤0.01% |
+68
| New | +$116K |
|
306
General Dynamics
GD
$106B
| $114K | ﹤0.01% |
+321
| New | +$110K |
|
307
Mettler-Toledo International
MTD
$28.6B
| $111K | ﹤0.01% |
+87
| New | +$105K |
|
308
Herc Holdings
HRI
$5.61B
| $110K | ﹤0.01% |
+768
| New | +$99.1K |
|
309
Novartis
NVS
$297B
| $110K | ﹤0.01% |
+700
| New | +$105K |
|
310
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.83B
| $109K | ﹤0.01% |
+834
| New | +$104K |
|
311
Strategy Inc
MSTR
$38.4B
| $109K | ﹤0.01% |
+1,250
| New | +$181K |
|
312
Clorox
CLX
$12.7B
| $108K | ﹤0.01% |
+1,135
| New | +$109K |
|
313
Progressive
PGR
$125B
| $106K | ﹤0.01% |
+485
| New | +$97.7K |
|
314
MasTec
MTZ
$21.9B
| $104K | ﹤0.01% |
+250
| New | +$95.6K |
|
315
Bunge Global
BG
$20.8B
| $100K | ﹤0.01% |
+940
| New | +$116K |
|
316
Uber
UBER
$153B
| $99.5K | ﹤0.01% |
+1,379
| New | +$101K |
|
317
General Mills
GIS
$19.7B
| $99K | ﹤0.01% |
+2,846
| New | +$98.3K |
|
318
Sprott Physical Gold
PHYS
$15.7B
| $98.1K | ﹤0.01% |
+3,250
| New | +$111K |
|
319
Comcast
CMCSA
$90B
| $97.9K | ﹤0.01% |
+3,989
| New | +$103K |
|
320
BP
BP
$107B
| $97.5K | ﹤0.01% |
+2,639
| New | +$116K |
|
321
Gilead Sciences
GILD
$165B
| $96.8K | ﹤0.01% |
+766
| New | +$101K |
|
322
Clean Harbors
CLH
$16.3B
| $92.6K | ﹤0.01% |
+310
| New | +$91.6K |
|
323
Invesco
IVZ
$13.9B
| $91.6K | ﹤0.01% |
+3,470
| New | +$92K |
|
324
HCA Healthcare
HCA
$89.5B
| $87.7K | ﹤0.01% |
+225
| New | +$95.1K |
|
325
Chemours
CC
$2.37B
| $86.8K | ﹤0.01% |
+4,232
| New | +$96.9K |
|
Similar funds
TI
LP
RIM
Evelyn Partners Group Ltd's Q2 2026 Portfolio in Review
Q2 2026 is the first quarter with a 13F filing on record for Evelyn Partners Group Ltd, which disclosed 551 positions worth $46.9B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is AstraZeneca: 2,237,205 shares worth $41.5B.
By sector, the portfolio is most concentrated in Healthcare at 90% of assets, followed by Technology and Financials.
- Evelyn Partners Group Ltd's largest Q2 2026 buy was AstraZeneca: 2,237,205 shares worth $41.5B.
- Evelyn Partners Group Ltd's ten largest holdings make up 94% of its $46.9B portfolio in Q2 2026.
- Evelyn Partners Group Ltd disclosed 551 positions in Q2 2026, its first 13F filing on record.
Based on Evelyn Partners Group Ltd's 13F filing for Q2 2026, filed 7 Aug 2026.